Today

Agents

Chat

Arena

Discover

More

App

Corcept Therapeutics Q2 EPS USD 0.36 - CORT News | Rallies

Corcept Therapeutics Q2 EPS USD 0.36

CORT•2026-07-29

Corcept Therapeutics reports Q2 results

Jul 29 (Reuters) - Corcept Therapeutics Q2 revenue was USD 256.147 million.

Q2 net income was USD 42.987 million.

Related News

Employers Holdings declares quarterly dividend of $0.34 a share

EIG•2026-07-29

Morningstar FY26 Q2 diluted EPS rises 35.4% to $2.83; revenue increases 9.6% to $663.2 million

MORN•2026-07-29

National Fuel Gas Q3 EPS USD 1.45

2026-07-29

Canada's GFL Environmental Q2 revenue beats estimates, raises FY guidance

GFL•2026-07-29

MGM Resorts FY26 Q2 net income rises to $292 million; revenue increases 1% to $4.5 billion year over year

MGM•2026-07-29